Aggressive hematopoietic malignancy characterized by biallelic loss of SMARCB1

Gespeichert in:
Bibliographische Detailangaben
Hauptverfasser: Kinnaman, Michael D. (VerfasserIn) , Hamill, Darcy (VerfasserIn) , Yabe, Mariko (VerfasserIn) , Powell, Jonathan (VerfasserIn) , Benhamida, Jamal (VerfasserIn) , Hasselblatt, Martin (VerfasserIn) , Neumann, Martin (VerfasserIn) , Vokuhl, Christian (VerfasserIn) , Kölsche, Christian (VerfasserIn) , Deimling, Andreas von (VerfasserIn) , Kolb, Edward Anders (VerfasserIn) , Solit, David B. (VerfasserIn) , Ladanyi, Marc (VerfasserIn) , Dogan, Ahmet (VerfasserIn) , Shukla, Neerav (VerfasserIn)
Dokumenttyp: Article (Journal)
Sprache:Englisch
Veröffentlicht: October 28, 2020
In: JCO precision oncology
Year: 2020, Jahrgang: 4, Pages: 1280-1284
ISSN:2473-4284
DOI:10.1200/PO.20.00215
Online-Zugang:Verlag, lizenzpflichtig, Volltext: https://doi.org/10.1200/PO.20.00215
Verlag, lizenzpflichtig, Volltext: https://ascopubs.org/doi/10.1200/PO.20.00215
Volltext
Verfasserangaben:Michael D. Kinnaman, MD; Darcy Hamill, DO; Mariko Yabe, MD; Jonathan Powell, MD; Jamal Benhamida, MD; Martin Hasselblatt, MD; Martin Neumann, MD; Christian Vokuhl, MD; Christian Koelsche, MD; Andreas von Deimling, MD; Edward Anders Kolb, MD; David B. Solit, MD; Marc Ladanyi, MD; Ahmet Dogan, MD; and Neerav Shukla, MD

MARC

LEADER 00000caa a2200000 c 4500
001 1750098210
003 DE-627
005 20220819123043.0
007 cr uuu---uuuuu
008 210302s2020 xx |||||o 00| ||eng c
024 7 |a 10.1200/PO.20.00215  |2 doi 
035 |a (DE-627)1750098210 
035 |a (DE-599)KXP1750098210 
035 |a (OCoLC)1341396585 
040 |a DE-627  |b ger  |c DE-627  |e rda 
041 |a eng 
084 |a 33  |2 sdnb 
100 1 |a Kinnaman, Michael D.  |e VerfasserIn  |0 (DE-588)1228343942  |0 (DE-627)1750098768  |4 aut 
245 1 0 |a Aggressive hematopoietic malignancy characterized by biallelic loss of SMARCB1  |c Michael D. Kinnaman, MD; Darcy Hamill, DO; Mariko Yabe, MD; Jonathan Powell, MD; Jamal Benhamida, MD; Martin Hasselblatt, MD; Martin Neumann, MD; Christian Vokuhl, MD; Christian Koelsche, MD; Andreas von Deimling, MD; Edward Anders Kolb, MD; David B. Solit, MD; Marc Ladanyi, MD; Ahmet Dogan, MD; and Neerav Shukla, MD 
246 3 3 |a Aggressive hematopoietic malignancy characterized by biallelic loss of SMARCB one 
264 1 |c October 28, 2020 
300 |a 5 
336 |a Text  |b txt  |2 rdacontent 
337 |a Computermedien  |b c  |2 rdamedia 
338 |a Online-Ressource  |b cr  |2 rdacarrier 
500 |a Gesehen am 02.03.2021 
700 1 |a Hamill, Darcy  |e VerfasserIn  |4 aut 
700 1 |a Yabe, Mariko  |e VerfasserIn  |4 aut 
700 1 |a Powell, Jonathan  |e VerfasserIn  |4 aut 
700 1 |a Benhamida, Jamal  |e VerfasserIn  |4 aut 
700 1 |a Hasselblatt, Martin  |e VerfasserIn  |4 aut 
700 1 |a Neumann, Martin  |e VerfasserIn  |4 aut 
700 1 |a Vokuhl, Christian  |e VerfasserIn  |4 aut 
700 1 |a Kölsche, Christian  |d 1983-  |e VerfasserIn  |0 (DE-588)1012485080  |0 (DE-627)661827313  |0 (DE-576)345469372  |4 aut 
700 1 |a Deimling, Andreas von  |d 1959-  |e VerfasserIn  |0 (DE-588)103034115X  |0 (DE-627)735093946  |0 (DE-576)378138065  |4 aut 
700 1 |a Kolb, Edward Anders  |e VerfasserIn  |4 aut 
700 1 |a Solit, David B.  |e VerfasserIn  |4 aut 
700 1 |a Ladanyi, Marc  |e VerfasserIn  |4 aut 
700 1 |a Dogan, Ahmet  |e VerfasserIn  |4 aut 
700 1 |a Shukla, Neerav  |e VerfasserIn  |4 aut 
773 0 8 |i Enthalten in  |t JCO precision oncology  |d Alexandria, VA : American Society of Clinical Oncology, 2017  |g 4(2020), Seite 1280-1284  |h Online-Ressource  |w (DE-627)1067396667  |w (DE-600)2964799-X  |w (DE-576)518266486  |x 2473-4284  |7 nnas  |a Aggressive hematopoietic malignancy characterized by biallelic loss of SMARCB1 
773 1 8 |g volume:4  |g year:2020  |g pages:1280-1284  |g extent:5  |a Aggressive hematopoietic malignancy characterized by biallelic loss of SMARCB1 
856 4 0 |u https://doi.org/10.1200/PO.20.00215  |x Verlag  |x Resolving-System  |z lizenzpflichtig  |3 Volltext 
856 4 0 |u https://ascopubs.org/doi/10.1200/PO.20.00215  |x Verlag  |z lizenzpflichtig  |3 Volltext 
951 |a AR 
992 |a 20210302 
993 |a Article 
994 |a 2020 
998 |g 103034115X  |a Deimling, Andreas von  |m 103034115X:Deimling, Andreas von  |d 910000  |d 912000  |e 910000PD103034115X  |e 912000PD103034115X  |k 0/910000/  |k 1/910000/912000/  |p 10 
998 |g 1012485080  |a Kölsche, Christian  |m 1012485080:Kölsche, Christian  |d 910000  |d 912000  |d 50000  |e 910000PK1012485080  |e 912000PK1012485080  |e 50000PK1012485080  |k 0/910000/  |k 1/910000/912000/  |k 0/50000/  |p 9 
999 |a KXP-PPN1750098210  |e 3879861471 
BIB |a Y 
SER |a journal 
JSO |a {"physDesc":[{"extent":"5 S."}],"name":{"displayForm":["Michael D. Kinnaman, MD; Darcy Hamill, DO; Mariko Yabe, MD; Jonathan Powell, MD; Jamal Benhamida, MD; Martin Hasselblatt, MD; Martin Neumann, MD; Christian Vokuhl, MD; Christian Koelsche, MD; Andreas von Deimling, MD; Edward Anders Kolb, MD; David B. Solit, MD; Marc Ladanyi, MD; Ahmet Dogan, MD; and Neerav Shukla, MD"]},"language":["eng"],"type":{"bibl":"article-journal","media":"Online-Ressource"},"origin":[{"dateIssuedKey":"2020","dateIssuedDisp":"October 28, 2020"}],"note":["Gesehen am 02.03.2021"],"title":[{"title":"Aggressive hematopoietic malignancy characterized by biallelic loss of SMARCB1","title_sort":"Aggressive hematopoietic malignancy characterized by biallelic loss of SMARCB1"}],"id":{"doi":["10.1200/PO.20.00215"],"eki":["1750098210"]},"relHost":[{"pubHistory":["Volume 1 (2017)-"],"titleAlt":[{"title":"JCO PO"}],"recId":"1067396667","title":[{"title_sort":"JCO precision oncology","title":"JCO precision oncology","subtitle":"an American Society of Clinical Oncology journal"}],"id":{"issn":["2473-4284"],"eki":["1067396667"],"zdb":["2964799-X"]},"disp":"Aggressive hematopoietic malignancy characterized by biallelic loss of SMARCB1JCO precision oncology","note":["Gesehen am 06.07.21"],"part":{"text":"4(2020), Seite 1280-1284","volume":"4","extent":"5","year":"2020","pages":"1280-1284"},"physDesc":[{"extent":"Online-Ressource"}],"language":["eng"],"origin":[{"publisherPlace":"Alexandria, VA","dateIssuedKey":"2017","dateIssuedDisp":"2017-","publisher":"American Society of Clinical Oncology"}],"type":{"media":"Online-Ressource","bibl":"periodical"}}],"person":[{"family":"Kinnaman","roleDisplay":"VerfasserIn","display":"Kinnaman, Michael D.","role":"aut","given":"Michael D."},{"family":"Hamill","roleDisplay":"VerfasserIn","given":"Darcy","role":"aut","display":"Hamill, Darcy"},{"family":"Yabe","roleDisplay":"VerfasserIn","role":"aut","display":"Yabe, Mariko","given":"Mariko"},{"given":"Jonathan","display":"Powell, Jonathan","role":"aut","roleDisplay":"VerfasserIn","family":"Powell"},{"family":"Benhamida","roleDisplay":"VerfasserIn","given":"Jamal","display":"Benhamida, Jamal","role":"aut"},{"display":"Hasselblatt, Martin","role":"aut","given":"Martin","family":"Hasselblatt","roleDisplay":"VerfasserIn"},{"roleDisplay":"VerfasserIn","family":"Neumann","display":"Neumann, Martin","role":"aut","given":"Martin"},{"role":"aut","display":"Vokuhl, Christian","given":"Christian","roleDisplay":"VerfasserIn","family":"Vokuhl"},{"given":"Christian","display":"Kölsche, Christian","role":"aut","roleDisplay":"VerfasserIn","family":"Kölsche"},{"given":"Andreas von","display":"Deimling, Andreas von","role":"aut","roleDisplay":"VerfasserIn","family":"Deimling"},{"given":"Edward Anders","display":"Kolb, Edward Anders","role":"aut","roleDisplay":"VerfasserIn","family":"Kolb"},{"role":"aut","display":"Solit, David B.","given":"David B.","roleDisplay":"VerfasserIn","family":"Solit"},{"display":"Ladanyi, Marc","role":"aut","given":"Marc","roleDisplay":"VerfasserIn","family":"Ladanyi"},{"roleDisplay":"VerfasserIn","family":"Dogan","role":"aut","display":"Dogan, Ahmet","given":"Ahmet"},{"given":"Neerav","display":"Shukla, Neerav","role":"aut","family":"Shukla","roleDisplay":"VerfasserIn"}],"titleAlt":[{"title":"Aggressive hematopoietic malignancy characterized by biallelic loss of SMARCB one"}],"recId":"1750098210"} 
SRT |a KINNAMANMIAGGRESSIVE2820